AS.US
Founded in 1950 in Helsinki, Finland, Amer was purchased in 2019 by an Anta-led consortium whose other members included private equity fund FountainVest Partners, Lululemon founder Chip Wilson and internet giant Tencent.

The Latest: Amer Sports Inc. (AS.US), the international unit spun off by sportswear maker Anta Sports (2020.HK), reported Tuesday that its revenue rose 13% to $1.18 billion in the first quarter of 2024, as its China revenue jumped 51% to $310 million.

Looking Up: Revenue from the company’s technical apparel division rose 44% to $510 million on the back of strong performance by its high-end Arc’teryx brand. The company said strong growth from the brand would be an important driver going forward.

Take Note: The company’s ball and racquet sports business, which includes the Wilson brand, reported a 14% sales decline to $273 million.

Digging Deeper: Founded in 1950 in Helsinki, Finland, Amer was purchased in 2019 by an Anta-led consortium whose other members included private equity fund FountainVest Partners, Lululemon founder Chip Wilson and internet giant Tencent (0700.HK). It currently owns several sporting brands, including Wilson and Arc’teryx, and sells its products in more than 100 countries. Its revenue has grown rapidly in recent years despite the pandemic, and it successfully listed in the U.S. in January. The company expects its revenue to grow 15% this year, with a gross profit margin of around 54%.

Market Reaction: Amer shares fell 7.9% to $14.76 on Tuesday, though they are still 13.5% above their IPO price of $13.

Translation by A. Au

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Man Wah subsidiary Remacro NEEQ listing

Man Wah sets spin-off in motion for its sofa tech unit

The Chinese furniture giant is preparing to list its components subsidiary Remacro to raise the technology unit’s profile and open an independent funding channel Key Takeaways: After listing on China’s…
WuXi AppTec partnering with Saudi authorities

WuXi AppTec frees up money for Middle East push

The drugs services giant has stepped up sales of non-core Chinese assets to concentrate on its international expansion, with plans for a base in Saudi Arabia Key Takeaways: The company…